Literature DB >> 16002724

Alterations in nitric oxide and cytokine production with airway inflammation in the absence of IL-10.

Bill T Ameredes1, Ruben Zamora, Jigme M Sethi, He-Liang Liu, Lauryn K Kohut, Amber L Gligonic, Augustine M K Choi, William J Calhoun.   

Abstract

IL-10 is an anti-inflammatory cytokine that suppresses NO synthase (NOS) and production of NO; its lack may promote NO production and alterations in cytokines modulated by NO with allergic airway inflammation (AI), such as IL-18 and IL-4. Therefore, we induced AI in IL-10 knockout ((-/-)) and IL-10-sufficient C57BL/6 (C57) mice with inhaled OVA and measured airway NO production, as exhaled NO (E(NO)) and bronchoalveolar lavage fluid nitrite levels. E(NO) and nitrite levels were elevated significantly in naive IL-10(-/-) mice as compared with C57 mice. With AI, E(NO) and nitrite levels increased in C57 mice and decreased in IL-10(-/-) mice. IL-18 production fell with both AI and addition of S-nitroso-N-acetyl-d,l-penicillamine (a NO donor) but was not significantly increased by chemical NOS inhibition by l-N(5)-(1-iminoethyl)-ornithine. IL-4 AI was increased significantly (up to 10-fold greater) in the absence of IL-10 but was reduced significantly with chemical inhibition of NOS. Airway responsiveness was lower in IL-10(-/-) mice and was associated with alteration in production of NO and IL-4. Thus, IL-4 production was increased, and likely decreased NO production, in a way not predicted by the absence of IL-10. Inhibition of IL-4 production, with inhibition of NOS in the absence of IL-10, demonstrated the importance of a NO and IL-4 feedback mechanism regulating this interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002724     DOI: 10.4049/jimmunol.175.2.1206

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin.

Authors:  Stavros Garantziotis; David M Brass; Jordan Savov; John W Hollingsworth; Erin McElvania-TeKippe; Katie Berman; Julia K L Walker; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-29       Impact factor: 6.914

2.  Decreased Bronchial Eosinophilic Inflammation and Mucus Hypersecretion in Asthmatic Mice Lacking All Nitric Oxide Synthase Isoforms.

Authors:  Kentaro Akata; Kazuhiro Yatera; Ke-Yong Wang; Keisuke Naito; Takaaki Ogoshi; Shingo Noguchi; Takashi Kido; Yumiko Toyohira; Hiroaki Shimokawa; Nobuyuki Yanagihara; Masato Tsutsui; Hiroshi Mukae
Journal:  Lung       Date:  2015-12-19       Impact factor: 2.584

3.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

4.  Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion.

Authors:  Flávia Mafra de Lima; Luana Vitoretti; Fernando Coelho; Regiane Albertini; Ana Cristina Breithaupt-Faloppa; Wothan Tavares de Lima; Flávio Aimbire
Journal:  Lasers Med Sci       Date:  2012-05-05       Impact factor: 3.161

Review 5.  Mechanisms of Heightened Airway Sensitivity and Responses to Inhaled SO2 in Asthmatics.

Authors:  Anita L Reno; Edward G Brooks; Bill T Ameredes
Journal:  Environ Health Insights       Date:  2015-04-01

Review 6.  Role of IL-10 in the resolution of airway inflammation.

Authors:  Yoshiko Ogawa; Enrico A Duru; Bill T Ameredes
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.616

7.  Non-invasive measurements of exhaled NO and CO associated with methacholine responses in mice.

Authors:  Jigme M Sethi; Augustine M K Choi; William J Calhoun; Bill T Ameredes
Journal:  Respir Res       Date:  2008-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.